81 related articles for article (PubMed ID: 6152214)
1. The ergolene derivative MPME induces in the rat a behavioural syndrome associated with activation of dopamine D-1 receptors belonging to the dotted type of forebrain dopamine nerve terminals.
Ogren SO; Fuxe K; Angeby K; Köhler C
Eur J Pharmacol; 1984 Oct; 106(1):79-89. PubMed ID: 6152214
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
Fuxe K; Fredholm BB; Agnati LF; Corrodi H
Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
[TBL] [Abstract][Full Text] [Related]
3. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
4. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
[TBL] [Abstract][Full Text] [Related]
5. Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.
Kujacic M; Svensson K; Löfberg L; Carlsson A
J Neural Transm Gen Sect; 1991; 84(3):195-209. PubMed ID: 1679336
[TBL] [Abstract][Full Text] [Related]
6. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
Meller E; Bordi F; Bohmaker K
Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
[TBL] [Abstract][Full Text] [Related]
7. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
8. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
[TBL] [Abstract][Full Text] [Related]
9. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
Wachtel H; Kehr W; Sauer G
Life Sci; 1983 Dec; 33(26):2583-97. PubMed ID: 6607392
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Arnt J; Hyttel J
Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
[TBL] [Abstract][Full Text] [Related]
11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
Arnt J; Hyttel J; Perregaard J
Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
14. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
Arnt J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
[TBL] [Abstract][Full Text] [Related]
15. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
[TBL] [Abstract][Full Text] [Related]
16. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
Molloy AG; Waddington JL
Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
[TBL] [Abstract][Full Text] [Related]
17. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats.
Arnt J; Hyttel J; Meier E
Eur J Pharmacol; 1988 Oct; 155(1-2):37-47. PubMed ID: 2907491
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
20. Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin.
Ervin GN; Nemeroff CB
Neuropsychopharmacology; 1988 Sep; 1(3):243-50. PubMed ID: 3150806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
